FDA Plans New Rules On Food Standards Petitions, HCT/P Inspections

FDA has added three new proposed rules to its regulatory agenda for this year focused on food standards petitions, requirements for entities that manufacture human cell and tissue products, and regulations regarding the list of drugs that cannot be compounded because they have been withdrawn or removed from the market. The agency included the new proposed rules on its unified agenda unveiled Jan. 4. The first new proposal, “Food Standards; General Principles and Food Standards Modernization,” is slated for release...